Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

6.18
Delayed Data
As of Aug 18
 -0.19 / -2.98%
Today’s Change
4.76
Today|||52-Week Range
8.24
+3.87%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close6.37
Today’s open6.45
Day’s range6.10 - 6.45
Volume7,830
Average volume (3 months)7,520
Market cap$31.2M
Dividend yield--
Data as of 3:59pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-68.42%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.69%
P/E ratio77.3
Price/Sales2.70
Price/Book1.52

Competitors

 Today’s
change
Today’s
% change
ALPNAlpine Immune Scienc...-0.04-0.49%
ALTAltimmune Inc+0.01+0.49%
BPTHBio Path Holdings In...+0.02+8.12%
MTEMMolecular Templates ...-0.01-0.19%
Data as of 4:00pm ET, 08/18/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$9.5M
Annual profit (last year)$508.4K
Net profit margin5.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts